Issue 2/2014
WCN 2013 Satellite Symposium "Kidney and Lipids"
Content (35 Articles)
Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency
Shuma Hirashio, Toshinori Ueno, Takayuki Naito, Takao Masaki
Pathology of glomerular lipidosis
Hiroshi Sato, Nobuyuki Takahashi, Emiko Sato, Kiyomi Kisu, Sadayoshi Ito, Takao Saito
Treatment and impact of dyslipidemia in diabetic nephropathy
Tadashi Toyama, Miho Shimizu, Kengo Furuichi, Shuichi Kaneko, Takashi Wada
Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathy
Daisuke Koya, Munehiro Kitada, Shinji Kume, Keizo Kanasaki
Topics in lipoprotein glomerulopathy: an overview
Takao Saito, Akira Matsunaga, Kenji Ito, Hitoshi Nakashima
Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia
Akira Matsunaga, Takao Saito
A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy
Efstratios Stratikos, Angeliki Chroni
Causes and consequences of lipoprotein(a) abnormalities in kidney disease
Florian Kronenberg
The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease
Sethu M. Madhavan, John F. O’Toole
Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease
Kerry-Anne Rye
Chronic kidney disease induced dysfunction of high density lipoprotein
Suguru Yamamoto, Valentina Kon
Serum lipids and prevention of atherosclerotic cardiovascular events in hemodialysis patients
Tetsuo Shoji
In vivo kinetic studies to further understand pathogenesis of abnormal lipoprotein metabolism in chronic kidney disease
Katsunori Ikewaki
Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease
Nosratola D. Vaziri
Fabry disease: experience of screening dialysis patients for Fabry disease
Eiji Kusano, Osamu Saito, Tetsu Akimoto, Yasushi Asano
Results of the 4D study: ten years of follow-up?
Christoph Wanner, Kai-Renke Schmidt, Vera Krane
Do statins play a role in renoprotection?
Masato Kasahara, Takahiko Nakagawa, Hideki Yokoi, Takashige Kuwabara, Shinji Yasuno, Kiyoshi Mori, Masashi Mukoyama, Kenji Ueshima
Beneficial effect of LDL-apheresis in refractory nephrotic syndrome
Eri Muso
Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs
Vito M. Campese
The Asia Pacific Meeting for Vasculitis and ANCA Workshop 2012: surgical treatment for Takayasu’s arteritis
Tetsuro Miyata
Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency
Miho Shimizu, Kengo Furuichi, Hitoshi Yokoyama, Tadashi Toyama, Yasunori Iwata, Norihiko Sakai, Shuichi Kaneko, Takashi Wada
Knee extensor muscle strength and index of renal function associated with an exercise capacity of 5 metabolic equivalents in male chronic heart failure patients with chronic kidney disease
Chiharu Hotta, Koji Hiraki, Satoshi Watanabe, Kazuhiro P. Izawa, Takashi Yasuda, Naohiko Osada, Kazuto Omiya, Kenjiro Kimura
Comparison between consecutive and intermittent steroid pulse therapy combined with tonsillectomy for clinical remission of IgA nephropathy
Daigo Kamei, Takahito Moriyama, Takashi Takei, Sachiko Wakai, Kosaku Nitta
Characteristics and 3-year mortality and infection rates among incident hemodialysis patients with a permanent catheter undergoing a first vascular access conversion
Yee-Yung Ng, Yen-Ni Hung, Shiao-Chi Wu, Po-Jen Ko